Immediate Impact

58 standout
Sub-graph 1 of 22

Citing Papers

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
2025 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
3 intermediate papers

Works of Igor Lifirenko being referenced

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
2011

Author Peers

Author Last Decade Papers Cites
Igor Lifirenko 117 22 95 83 4 180
Grant Creaney 92 34 1 146 72 3 296
Averdi Roezin 115 8 20 94 29 4 224
Yan-Fang Ye 76 19 2 101 44 7 167
Anthony Provenzano 63 19 163 102 2 209
S Whelan 92 14 1 151 73 7 299
Mario López 65 139 31 87 6 283
Jia-Wei Lv 136 13 1 39 93 8 264
María José Echarri 99 25 18 71 7 143
Soheil Yala 118 6 42 101 6 286
Sebastião Francisco Miranda Corrêa 44 42 136 101 5 284

All Works

Loading papers...

Rankless by CCL
2026